Stoke Therapeutics

Price & Volume

Stats

52W Range	$5.35-$17.58
Market Cap	$539.4M
Shares Short	12M

Financials

Revenue (12 Mos)	$36.5M
Revenue Growth (YoY)	707.1%
Gross Profit (12 Mos)	$36.5M
Diluted EPS	-$1.65

News

Yahoo Finance • last year

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Stoke Therapeutics, Inc. (NASDAQ: STOK) and Encourages Investors to Contact the Firm

Yahoo Finance • last year

Investor Alert: Abbott Cooper PLLC Announces Investigation into Stoke Therapeutics, Inc.; Urges Stoke Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

Yahoo Finance • 2 years ago

Stoke Therapeutics Receives Authorization to Initiate a Phase 1/2 Study of STK-002 for Autosomal Dominant Optic Atrophy (ADOA) in the United Kingdom

About

CEO	Mr. Ian F. Smith A.C.A., C.P.A.
Address	45 Wiggins Avenue, Bedford, MA, United States, 01730
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	128